about-us-about-img
About Us

What is Liver Cancer Surgery

Liver cancer surgery aims to remove tumors while preserving healthy liver tissue. Types we treat

  • Hepatocellular Carcinoma (HCC): Primary liver cancer is often linked to cirrhosis or hepatitis.
  • Metastatic Liver Tumors: Spread from colorectal, breast, or pancreatic cancers.
  • Cholangiocarcinoma: Bile duct cancer requiring complex resections.
    Key Goals:
  • Curative Surgery: Complete tumor removal for early-stage HCC or isolated metastases.
  • Palliative Care: Relieve symptoms and prolong survival in advanced cases.
Read More
about-quote-img

The power of community to create health is far greater than any physician, clinic or hospital.

  • successful transplants
    1000+
    successful liver transplants
  • infrastructure
    State-of-the-Art
    Infrastructure
  • success rate
    95%+
    success rate
  • affordable cost
    Affordable Liver
    Transplant Cost in Delhi
Cancer Surgery
Book a Consultation

Schedule an appointment with our specialists

Book Now

Advanced Liver Cancer Surgery In Delhi

Cutting-edge surgical oncology with 80% 5-year survival for early HCC

Advanced Liver Cancer Surgery Techniques

1. Surgical Resection

  • Partial Hepatectomy: Removal of liver segments affected by HCC or metastases
  • Extended Resections: For large tumors, combined with portal vein embolization (PVE) to grow healthy liver tissue pre-surgery

2. Minimally Invasive Approaches

  • Laparoscopic/Robotic Surgery: Smaller incisions, faster recovery (4–6 weeks)
  • Radiofrequency Ablation (RFA): Destroys small tumors (<3 cm) with heat

3. Pre-Surgical Therapies

  • Chemotherapy Before Liver Cancer Surgery: Shrinks tumors for safer resection (e.g., FOLFOX for colorectal metastases)
  • Targeted Therapy: Bevacizumab or sorafenib to reduce recurrence risk

80%

5-year survival for early HCC

50%

Tumor shrinkage with pre-op chemo

Why Choose Liver Surgeon for Liver Cancer Surgery?

Dr. Ashish George – Premier Liver Cancer Surgery Specialist

  • 15+ Years' Expertise: Performed 300+ liver resections, including high-risk HCC and metastatic cases
  • Global Training: Fellowships at Mayo Clinic and King's College Hospital

Pioneered Advanced Techniques

  • PVE: Prevents post-resection liver failure by boosting healthy lobe growth
  • Hybrid RFA-Resection: Combines ablation and surgery for complex tumors

Cutting-Edge Technology

  • Intraoperative Ultrasound: Maps tumors in real-time for precise resection
  • ICG Fluorescence Imaging: Identifies microscopic cancer cells

Holistic Care

  • Enhanced Recovery Protocols: Minimize pain and hospital stays
  • Post-Surgery Surveillance: Lifelong imaging and blood tests to catch recurrence early

300+

Liver resections performed

80%

5-year HCC survival

Your Liver Cancer Journey Starts with Expertise – Act Now!

Testimonials

What Our Patient's are Saying

GET ANSWERS

Liver Cancer Surgery FAQs

For early-stage HCC, 80% survive 5+ years post-curative resection. Metastatic cases vary by origin but average 40–60% 3-year survival with combined chemo/surgery.

For tumors <3 cm, RFA achieves outcomes similar to surgery but with fewer complications. Dr. Ashish George’s Delhi team uses CT-guided RFA for precision.

Blocking blood flow to the tumor-bearing lobe triggers healthy lobe growth, reducing post-surgery liver failure risks.

No. Living donor transplants are contraindicated for HCC patients due to recurrence risks.

Eligibility depends on tumor size, location, and liver function. Dr. Ashish George’s Delhi team prioritizes patients with:
• Early-stage HCC (single tumor <5 cm or up to 3 tumors <3 cm).
• Adequate liver reserve (Child-Pugh A/B cirrhosis).
• No major blood vessel invasion.
Advanced imaging and portal vein embolization (PVE) expand options for borderline cases.

For minimally invasive surgery (laparoscopic/robotic), recovery takes 4–6 weeks. Open hepatectomy requires 8–12 weeks. Our Delhi center’s Enhanced Recovery After Surgery (ERAS) protocols reduce pain and accelerate healing.

Pre-op chemo (e.g., FOLFOX for colorectal metastases) shrinks tumors in 50–60% of cases, enabling safer resection. Dr. Ashish George combines chemo with targeted therapies (bevacizumab) to maximize success rates.

Recurrence occurs in 20–30% of HCC cases. Our multidisciplinary team in Delhi monitors patients with:
• 3-monthly CT/MRI scans.
• AFP tumor marker tests.
• Salvage therapies like RFA, TACE, or immunotherapy for early detection.